載入...
PLGA Nanoparticle-Based Formulations to Cross the Blood–Brain Barrier for Drug Delivery: From R&D to cGMP
The blood–brain barrier (BBB) is a natural obstacle for drug delivery into the human brain, hindering treatment of central nervous system (CNS) disorders such as acute ischemic stroke, brain tumors, and human immunodeficiency virus (HIV)-1-associated neurocognitive disorders. Poly(lactic-co-glycolic...
Na minha lista:
| 發表在: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8067506/ https://ncbi.nlm.nih.gov/pubmed/33917577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13040500 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|